* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.
NLY01 is a long-acting, microglia-targeted GLP-1R agonist, which is undergoing clinical trials for the treatment of Parkinson's Disease and Alzheimer's Disease.
